{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:48:30Z","timestamp":1740138510355,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12035-021-02396-9","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T22:03:49Z","timestamp":1619474629000},"page":"3983-3991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-4863","authenticated-orcid":false,"given":"Blair","family":"Ney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3226-7645","authenticated-orcid":false,"given":"Dhamidhu","family":"Eratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-6308","authenticated-orcid":false,"given":"Victoria","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-8366","authenticated-orcid":false,"given":"Luke","family":"Ney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-3763","authenticated-orcid":false,"given":"Qiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8282-9151","authenticated-orcid":false,"given":"Christiane","family":"Stehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-6611","authenticated-orcid":false,"given":"Steven","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8842-8479","authenticated-orcid":false,"given":"Dennis","family":"Velakoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"2396_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(05)70192-7","volume":"4","author":"RT Johnson","year":"2005","unstructured":"Johnson RT (2005) Prion diseases. Lancet Neurol 4:635\u2013642","journal-title":"Lancet Neurol"},{"key":"2396_CR2","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci 95:13363\u201313383","journal-title":"Proc Natl Acad Sci"},{"key":"2396_CR3","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.1073\/pnas.83.19.7358","volume":"83","author":"RS Sparkes","year":"1986","unstructured":"Sparkes RS, Simon M, Cohn VH et al (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci 83:7358\u20137362","journal-title":"Proc Natl Acad Sci"},{"key":"2396_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1073\/pnas.97.1.145","volume":"97","author":"R Zahn","year":"2000","unstructured":"Zahn R, Liu A, L\u00fchrs T et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci 97:145\u2013150","journal-title":"Proc Natl Acad Sci"},{"key":"2396_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nsb0901-770","volume":"8","author":"KJ Knaus","year":"2001","unstructured":"Knaus KJ, Morillas M, Swietnicki W et al (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8:770\u2013774","journal-title":"Nat Struct Biol"},{"key":"2396_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1126\/science.1675487","volume":"252","author":"SB Prusiner","year":"1991","unstructured":"Prusiner SB (1991) Molecular biology of prion diseases. Science 252:1515\u20131522","journal-title":"Science"},{"key":"2396_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930\u2013936","journal-title":"Science"},{"key":"2396_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","volume":"31","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Baumann F, Bremer J (2008) The prion\u2019s elusive reason for being. Annu Rev Neurosci 31:439\u2013477","journal-title":"Annu Rev Neurosci"},{"key":"2396_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/19336896.2019.1569450","volume":"13","author":"IV Baskakov","year":"2019","unstructured":"Baskakov IV, Caughey B, Requena JR et al (2019) The prion 2018 round tables (I): the structure of PrPSc. Prion 13:46\u201352","journal-title":"Prion"},{"key":"2396_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12035-014-8758-x","volume":"50","author":"C Tian","year":"2014","unstructured":"Tian C, Liu D, Xiang W et al (2014) Analyses of the similarity and difference of global gene expression profiles in cortex regions of three neurodegenerative diseases: sporadic Creutzfeldt-Jakob disease (sCJD), fatal familial insomnia (FFI), and Alzheimer\u2019s disease (AD). Mol Neurobiol 50:473\u2013481","journal-title":"Mol Neurobiol"},{"key":"2396_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tmrv.2007.09.003","volume":"22","author":"S Zou","year":"2008","unstructured":"Zou S, Fang CT, Schonberger LB (2008) Transfusion transmission of human prion diseases. Transfus Med Rev 22:58\u201369","journal-title":"Transfus Med Rev"},{"key":"2396_CR12","doi-asserted-by":"publisher","first-page":"34848","DOI":"10.1074\/jbc.M602238200","volume":"281","author":"J Yuan","year":"2006","unstructured":"Yuan J, Xiao X, McGeehan J et al (2006) Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem 281:34848\u201334858","journal-title":"J Biol Chem"},{"key":"2396_CR13","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2015.8.FOCUS15328","volume":"39","author":"M Manix","year":"2015","unstructured":"Manix M, Kalakoti P, Henry M et al (2015) Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus 39:E2","journal-title":"Neurosurg Focus"},{"key":"2396_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6821","volume":"5","author":"H Cassard","year":"2014","unstructured":"Cassard H, Torres J-M, Lacroux C et al (2014) Evidence for zoonotic potential of ovine scrapie prions. Nat Commun 5:1\u20139","journal-title":"Nat Commun"},{"key":"2396_CR15","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3201\/eid2606.181790","volume":"26","author":"A Marin-Moreno","year":"2020","unstructured":"Marin-Moreno A, Huor A, Espinosa JC et al (2020) Radical change in zoonotic abilities of atypical BSE prion strains as evidenced by crossing of sheep species barrier in transgenic mice. Emerg Infect Dis 26:1130","journal-title":"Emerg Infect Dis"},{"key":"2396_CR16","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1212\/01.WNL.0000145844.53251.BC","volume":"63","author":"L Linsell","year":"2004","unstructured":"Linsell L, Cousens SN, Smith PG et al (2004) A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. Neurology 63:2077\u20132083","journal-title":"Neurology"},{"key":"2396_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/jnnp-2012-304820","volume":"84","author":"GMJA Klug","year":"2013","unstructured":"Klug GMJA, Wand H, Simpson M et al (2013) Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatr 84:1372\u20131377","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"2396_CR18","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJM199712183372508","volume":"337","author":"AM Haywood","year":"1997","unstructured":"Haywood AM (1997) Transmissible spongiform encephalopathies. N Engl J Med 337:1821\u20131828","journal-title":"N Engl J Med"},{"key":"2396_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G et al (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618\u2013628","journal-title":"Lancet Neurol"},{"key":"2396_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0140-6736(05)63366-1","volume":"350","author":"M Zeidler","year":"1997","unstructured":"Zeidler M, Stewart G, Cousens SN et al (1997) Codon 129 genotype and new variant CJD. Lancet 350:668","journal-title":"Lancet"},{"key":"2396_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340\u2013342","journal-title":"Nature"},{"key":"2396_CR22","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-V","volume":"337","author":"J Collinge","year":"1991","unstructured":"Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441\u20131442","journal-title":"Lancet"},{"key":"2396_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3201\/eid2309.161948","volume":"23","author":"N Fern\u00e1ndez-Borges","year":"2017","unstructured":"Fern\u00e1ndez-Borges N, Espinosa JC, Marin-Moreno A et al (2017) Protective effect of Val129-PrP against bovine spongiform encephalopathy but not variant Creutzfeldt-Jakob disease. Emerg Infect Dis 23:1522","journal-title":"Emerg Infect Dis"},{"key":"2396_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S, Wadsworth JDF et al (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333\u20131346","journal-title":"Brain"},{"key":"2396_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767\u2013778","journal-title":"Ann Neurol"},{"key":"2396_CR26","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1073\/pnas.0809170106","volume":"106","author":"SV Antonyuk","year":"2009","unstructured":"Antonyuk SV, Trevitt CR, Strange RW et al (2009) Crystal structure of human prion protein bound to a therapeutic antibody. Proc Natl Acad Sci 106:2554\u20132558","journal-title":"Proc Natl Acad Sci"},{"key":"2396_CR27","doi-asserted-by":"publisher","first-page":"29671","DOI":"10.1074\/jbc.C110.158303","volume":"285","author":"MI Apostol","year":"2010","unstructured":"Apostol MI, Sawaya MR, Cascio D, Eisenberg D (2010) Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease. J Biol Chem 285:29671\u201329675","journal-title":"J Biol Chem"},{"key":"2396_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge J, Sidle KCL, Meads J et al (1996) Molecular analysis of prion strain variation and the aetiology of \u201cnew variant\u201d CJD. Nature 383:685\u2013690","journal-title":"Nature"},{"key":"2396_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/9030","volume":"1","author":"JDF Wadsworth","year":"1999","unstructured":"Wadsworth JDF, Hill AF, Joiner S et al (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1:55\u201359","journal-title":"Nat Cell Biol"},{"key":"2396_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233","journal-title":"Ann Neurol"},{"key":"2396_CR31","doi-asserted-by":"publisher","first-page":"40377","DOI":"10.1074\/jbc.C100458200","volume":"276","author":"G Zanusso","year":"2001","unstructured":"Zanusso G, Farinazzo A, Fiorini M et al (2001) pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. J Biol Chem 276:40377\u201340380","journal-title":"J Biol Chem"},{"key":"2396_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent. Nature 389:498\u2013501","journal-title":"Nature"},{"key":"2396_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill AF, Desbruslais M, Joiner S et al (1997) The same prion strain causes vCJD and BSE. Nature 389:448\u2013450","journal-title":"Nature"},{"key":"2396_CR34","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1093\/brain\/awl224","volume":"129","author":"I Cali","year":"2006","unstructured":"Cali I, Castellani R, Yuan J et al (2006) Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 129:2266\u20132277","journal-title":"Brain"},{"key":"2396_CR35","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/brain\/awl225","volume":"129","author":"MW Head","year":"2006","unstructured":"Head MW, Ironside JW (2006) Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein. Brain 129:2238\u20132240","journal-title":"Brain"},{"key":"2396_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, De Boni L, Saverioni D et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529","journal-title":"Acta Neuropathol"},{"key":"2396_CR37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","volume":"19","author":"P Parchi","year":"2009","unstructured":"Parchi P, Notari S, Weber P et al (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: a western blot study within the NeuroPrion Consortium. Brain Pathol 19:384\u2013391","journal-title":"Brain Pathol"},{"key":"2396_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659\u2013671","journal-title":"Acta Neuropathol"},{"key":"2396_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bpa.12695","volume":"29","author":"S Baiardi","year":"2019","unstructured":"Baiardi S, Rossi M, Capellari S, Parchi P (2019) Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol 29:278\u2013300","journal-title":"Brain Pathol"},{"key":"2396_CR40","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/01.WNL.0000031793.11602.8C","volume":"59","author":"S Collins","year":"2002","unstructured":"Collins S, Boyd A, Lee JS et al (2002) Creutzfeldt-Jakob disease in Australia 1970\u20131999. Neurology 59:1365\u20131371","journal-title":"Neurology"},{"key":"2396_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1212\/01.wnl.0000167188.65787.a0","volume":"65","author":"V Lewis","year":"2005","unstructured":"Lewis V, Hill AF, Klug GM et al (2005) Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 65:113\u2013118","journal-title":"Neurology"},{"key":"2396_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JAD-150247","volume":"48","author":"Q-X Li","year":"2015","unstructured":"Li Q-X, Villemagne VL, Doecke JD et al (2015) Alzheimer\u2019s disease normative cerebrospinal fluid biomarkers validated in PET amyloid-\u03b2 characterized subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Alzheimer\u2019s Dis 48:175\u2013187","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2396_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0004867419857811","volume":"54","author":"D Eratne","year":"2019","unstructured":"Eratne D, Loi SM, Walia N et al (2019) A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A \u2018C-reactive protein\u2019for psychiatrists and neurologists? Aust New Zeal J Psychiatr 54:57\u201367","journal-title":"Aust New Zeal J Psychiatr"},{"key":"2396_CR44","unstructured":"Team RC (2019) R: a language and environment for statistical computing (Version 3.5. 2, R Foundation for Statistical Computing, Vienna, Austria, 2018)"},{"key":"2396_CR45","unstructured":"JASP Team (2020) JASP (Version 0.12.2)[Computer software]"},{"key":"2396_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn3475","volume":"14","author":"KS Button","year":"2013","unstructured":"Button KS, Ioannidis JPA, Mokrysz C et al (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365\u2013376","journal-title":"Nat Rev Neurosci"},{"key":"2396_CR47","doi-asserted-by":"publisher","first-page":"36465","DOI":"10.1074\/jbc.M112.368803","volume":"287","author":"HMJ Klemm","year":"2012","unstructured":"Klemm HMJ, Welton JM, Masters CL et al (2012) The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. J Biol Chem 287:36465\u201336472","journal-title":"J Biol Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02396-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02396-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02396-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T04:44:52Z","timestamp":1626324292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02396-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02396-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"13 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection and storage was mediated through the Australian National Creutzfeldt-Jakob Disease Registry as per routine operations. Ethical approval for use of this data was gained through the University of Melbourne (Ethics ID: 1341074) and conforms with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Obtaining informed consent to participate is part of routine operations at the ANCJDR. Written informed consent to participate in research derived from ANCJDR operations was gained from all patients in this study, or where patients cannot provide informed consent, from the appropriate next of kin and\/or legal decision-maker.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Obtaining informed consent to publish patient data is also part of routine operations at the ANCJDR. The authors affirm that written informed consent for publication of patient data derived from ANCJDR operations was also gained from all patients in this study, or where patients cannot provide informed consent, from the appropriate next of kin and\/or legal decision-maker.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}